Full-Time

Senior Director of Data Engineering

Data Engineering + Integrations

Updated on 9/9/2026

Prolaio

Prolaio

51-200 employees

Real-time cardiovascular care analytics platform

Compensation Overview

$229k/yr

+ Performance bonus + Equity

Chicago, IL, USA

In Person

Bachelor's

Category
Engineering Management (1)
Required Skills
Microsoft Azure
Redshift
Python
React.js
Data Science
BigQuery
SQL
Java
Data Engineering
.NET
AWS
REST APIs
Data Modeling
Data Governance
Angular
Databricks
HIPAA
Data Analysis
Snowflake
Google Cloud Platform

Get referred to Prolaio

See people who can refer or advise you

Requirements
  • A Bachelor's degree in computer science, Data Engineering, Information Systems, Biomedical Informatics, Engineering, or a related field.
  • A minimum of 15 years of experience in healthcare, medtech, life sciences, digital health, or another patient-focused environment, with meaningful responsibility for data platforms, platform engineering, or cloud-native enterprise platforms.
  • At least 7 years of experience as a Director or Senior Director, or in an equivalent senior leadership role, leading data engineering or closely related data platform teams in growth-stage or innovation-driven organizations.
  • Demonstrated experience architecting and delivering healthcare data platforms that support structured, semi-structured, and unstructured data in regulated or validated environments.
  • Deep understanding of healthcare data domains, including clinical trials, cardiovascular and physiological data, real-world data, claims, medication, socio-economic and behavioral data, and healthcare terminologies and common data models such as HL7, FHIR, ICD, SNOMED CT, LOINC, RxNorm, OMOP, and CDISC.
  • Proven experience designing and operating end-to-end data flows, scalable pipelines, lineage, provenance, traceability, and data lifecycle management for product, analytics, data science, clinical operations, quality, and data services use cases.
  • Strong familiarity with cloud platforms such as GCP, AWS, or Azure and modern data platforms such as Snowflake, Databricks, BigQuery, Redshift, Synapse, or comparable environments, including orchestration, APIs, and integration.
  • Strong software engineering and data engineering experience with Python and SQL and at least one of Java or .NET, including building internal data platform features, services, and developer tooling.
  • Demonstrated ability to work effectively in cross-functional, matrixed organizations with Product, Engineering, Data Science, Analytics, Clinical Operations, Quality, and Security.
  • Familiarity with metadata, lineage, catalog, governance, and AI-enablement tools, including semantic indexing, vectorization, retrieval, data lifecycle automation, governed data access, and privacy-aware architectures.
Responsibilities
  • Lead the enterprise data engineering strategy and roadmap to deliver secure, scalable, and reliable data platform capabilities aligned to clinical, research, product, and AI priorities in regulated healthcare settings.
  • Architect and oversee end-to-end data flows and reusable pipelines for ingestion, validation, transformation, enrichment, publishing, retention, archival, and decommissioning across batch, streaming, and hybrid workloads.
  • Own the design and implementation of scalable, secure, and interoperable data platforms supporting structured, semi-structured, and unstructured clinical, operational, device, and patient-generated data.
  • Define and enforce engineering standards for data modeling, lifecycle management, lineage, provenance, traceability, and auditability, embedding HIPAA, privacy, security, and GxP-aligned practices into development workflows.
  • Partner with Data Architecture to design and govern conceptual, logical, and physical data models, apply healthcare standards, and deliver analysis-ready, interoperable datasets.
  • Build and evolve data engineering capabilities across modern cloud and data platforms, including orchestration, metadata, APIs, and integration patterns.
  • Lead development of AI-enabled data engineering features such as intelligent data quality monitoring, metadata enrichment, semantic search, feature generation workflows, and automation.
  • Collaborate with Quality, Clinical Operations, Security, Product, and Engineering to embed validation, change management, governed data access, master data management, and release readiness into the data platform lifecycle.
  • Establish and manage high-performing data engineering teams, providing clear ownership, coaching, and execution discipline while influencing architecture and implementation decisions across a matrixed organization.
  • Support vendor and tool evaluation, including build-versus-buy decisions for data integration, quality, metadata, lineage, interoperability, and AI-enabled data management capabilities.
Desired Qualifications
  • Experience with modern front-end frameworks such as Angular or React.
  • Experience developing agentic pipelines.

Prolaio provides a cardiovascular-focused health tech platform that helps healthcare providers improve patient outcomes through real-time data analytics and continuous monitoring. It collects data from electronic health records, patient surveys, and wearable sensors to build predictive models that warn care teams about potential health issues before they become critical. Healthcare providers access the platform via a subscription, giving them real-time analytics, alerts, and evidence-based care planning tools to monitor patients and optimize treatments. The company differentiates itself by concentrating on cardiovascular care and enabling continuous learning, patient engagement, and collaboration with pharmaceutical companies and research institutions to support new therapies. The overall goal is to reduce hospital admissions and readmissions while delivering timely, data-driven care that keeps patients healthier.

Company Size

51-200

Company Stage

Early VC

Total Funding

$25.5M

Headquarters

Scottsdale, Arizona

Founded

2022

Get referred to Prolaio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Kardigan’s June 2026 IPO raised $422.4 million, extending runway and platform investment.
  • OCORO Heart Study launched in 2026, expanding Prolaio’s remote data capture footprint.
  • Kardigan’s Q2 2026 update says Prolaio supports three late-stage programs and trial optimization.

What critics are saying

  • Kardigan now owns Prolaio; pipeline failures starve the platform by 2027.
  • Contingent milestone liabilities hit $47.3 million by June 30, 2026, pressuring economics.
  • Cardiovascular data regulation and privacy breaches can trigger FDA scrutiny and customer churn.

What makes Prolaio unique

  • FDA-cleared algorithms and 20-plus patents underpin Prolaio’s cardiovascular intelligence moat.
  • Prolaio spans 26 countries and four million patient-hours of curated CV data.
  • Kardigan still offers Prolaio industry-wide, not just inside its own trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Stock Options

Company Equity

Retirement Plan: 401(k) plan

Paid Time Off

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

-1%
Business Wire
Mar 28th, 2025
Kardigan Acquires Prolaio to Create a Pioneering Heart Health Company with One-of-a-Kind Integrated Cardiovascular Data and Therapeutics Platform

Kardigan, a heart health company modernizing cardiovascular (CV) drug development, announced today that it has acquired Prolaio, a clinical intelligence comp...

U.S. Securities and Exchange Commission
Sep 13th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.